CS Stage and TNM pN Breast

Home Forums Edits Vendor and Central Registry Metafile Administrators CS Stage and TNM pN Breast

Viewing 1 post (of 1 total)
  • Author
  • #3272
    AnonymousCathryn Phillips

    We are continuing to require collection of CS into 2016, as well as TNM. In a case with neoadjuvant breast cancer, a patient with positive clinical nodes, complete response. There appears to be a conflict related to TNM Path N, SSF 3, 4, 5:

    A patient had a positive LN aspiration, followed by neo-adjuvant chemo, followed by lumpectomy with no residual disease, with LN removal (0+/10 LNS)

    We code Regional Nodes Positive = 95 ( positive aspiration),
    Regional Nodes Exam = 10
    CS lymph nodes =257 (clinical eval > yp eval)
    CS lymph nodes eval = 5 (clinical > yp )
    Site Spec Factor 3 # positive ispilateral axillary LNS as 095
    Site Spec Factor 4 IHC of LNS 987 ( CS LYMPH nodes not coded 000)
    Site Spec Factor 5 MOL of LNS 987( CS LYMPH nodes not coded 000)
    Site Spec Factor 21REsonse to Neoadjuvant Rx 010 (complete)
    With the AJCC path coded as pT0,pN0, cM0, stage group 99, clinical stage descriptor 4 ( after tx)

Viewing 1 post (of 1 total)
  • The forum ‘Vendor and Central Registry Metafile Administrators’ is closed to new topics and replies.

Copyright © 2018 NAACCR, Inc. All Rights Reserved | naaccr-swoosh-only See NAACCR Partners and Sponsors